Accelerating vaccine development timelines with experience, expertise and automation: an interview with Cyrille Bonhomme
In this Spotlight podcast, we will discuss the development of vaccine assays, different types of assays available, specific expertise and tools needed to develop high throughput and robust assays, and the support needed for FDA approval. Additionally, we will explore ways to accelerate the timelines for vaccine development
About the speaker
Cyrille Bonhomme, PhD
Director, PPD Laboratory Services, Vaccine Sciences Lab
PPD, Part of Thermo Fisher Scientific (NC, USA)
Cyrille J. Bonhomme, PhD is Director of the PPD Laboratory Services (NC, USA), part of Thermo Fisher Scientifics Vaccine Sciences Department, and oversees the R&D laboratory activities. His academic experience focused on bacterial and viral infectious diseases. The R&D team supports several vaccine programs in various stages of development. He has extensive experience working with clients to move vaccine candidates through the clinical development pipeline, including regulatory submission.
Before joining PPD, Cyrille was a Senior Post Doctoral Fellow at UC Irvine (CA, USA) working on arenaviruses vaccines. Cyrille was responsible for the development of an arenavirus candidate vaccine.
Cyrille received his PhD in Microbiology and Infectious Diseases at the University of the Mediterranean (Marseille, France). His studies focused on developing diagnostics for various rare bacterial diseases.
This podcast is a part of the Bioanalysis Zone Spotlight feature on vaccine assay development. For more expert opinions on this topic, visit our feature homepage
In association with:
